Details for Patent: 9,173,847

Which drugs does patent 9,173,847 protect, and when does it expire?

Patent 9,173,847 protects FENOGLIDE and is included in one NDA.

This patent has twenty-nine patent family members in eleven countries.

Summary for Patent: 9,173,847

Title:	Tablet comprising a fibrate
Abstract:	Stable tablets and pharmaceutical compositions in particulate form comprising a fibrate, for example fenofibrate, dissolved or dispersed in an non-aqueous vehicle with improved bioavailability, thereby eliminating the food effect so that the tablet or composition can be administered to a patient irrespective of being in fed or fasted state.
Inventor(s):	Holm; Per (Vanlose, DK), Norling; Tomas (Lyngby, DK)
Assignee:	VELOXIS PHARMACEUTICALS A/S (Horsholm, DK)
Application Number:	11/449,918
Patent Claim Types: see list of patent claims	Compound; Dosage form; Composition; Formulation;

Drugs Protected by US Patent 9,173,847

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Salix	FENOGLIDE	fenofibrate	TABLET;ORAL	022118-001	Aug 10, 2007	AB	RX	Yes	No			Y
Salix	FENOGLIDE	fenofibrate	TABLET;ORAL	022118-002	Aug 10, 2007	AB	RX	Yes	Yes			Y

Foreign Priority and PCT Information for Patent: 9,173,847

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
Denmark	2005 00527	Apr 13, 2005

International Family Members for US Patent 9,173,847

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Australia	2004279661
Australia	2009201881
Brazil	PI0415121
Canada	2540984
Canada	2541382
Canada	2582403